Insights into Enhancing the chemosensitivity of metastatic breast cancers: Fulvestrant/Faslodex, a selective estrogen receptor down-regulator, sensitizes drug-resistant breast cancer cells by targeting Multidrug Resistance-Associated Protein 2 (MRP2)/ABCC2 through its target gene, 24/April/2014, 13.42

Insights into Enhancing the chemosensitivity of tumors: miRNA-545 sensitizes drug-resistant cancer cells by targeting Bcl-XL through its target gene, 24/April/2014, 13.30
April 24, 2014
A link between the regulation of Cell-density-dependent miRNA Biogenesis and tumor suppression: Fulvestrant/Faslodex, a selective estrogen receptor down-regulator, promotes widespread miRNA biogenesis via up regulation of its target gene, 24/April/2014, 13.53
April 24, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Insights into Enhancing the chemosensitivity of metastatic breast cancers: Fulvestrant/Faslodex, a selective estrogen receptor down-regulator, sensitizes drug-resistant breast cancer cells by targeting Multidrug Resistance-Associated Protein 2 (MRP2)/ABCC2 through its target gene, 24/April/2014, 13.42, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.